Independent Advisor Alliance Abbott Laboratories Transaction History

Independent Advisor Alliance

$2.71 Billion
Q3 2024

A detailed history of Independent Advisor Alliance transactions in Abbott Laboratories stock. As of the latest transaction made, Independent Advisor Alliance holds 69,318 shares of ABT stock, worth $7.86 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

69,318

Previous 70,639 1.87%

Holding current value

$7.86 Million

Previous $7.34 Million 7.66%

% of portfolio

0.29%

Previous 0.25%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $132,192 - $156,049	-1,321 Reduced 1.87%	69,318 $7.9 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $122,487 - $136,727	1,216 Added 1.75%	70,639 $7.34 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $232,839 - $257,160	-2,126 Reduced 2.97%	69,423 $7.89 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $359,587 - $440,164	-3,987 Reduced 5.28%	71,549 $7.88 Million
Q3 2023 Oct 24, 2023	SELL	$95.53 - $114.62 $252,294 - $302,711	-2,641 Reduced 3.38%	75,536 $7.32 Million
Q2 2023 Jul 28, 2023	SELL	$100.78 - $112.29 $1.15 Million - $1.28 Million	-11,427 Reduced 12.75%	78,177 $8.52 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $1.78 Million - $2.09 Million	-18,353 Reduced 17.0%	89,604 $9.07 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $770,841 - $904,315	-8,109 Reduced 6.99%	107,957 $11.9 Million
Q3 2022 Nov 04, 2022	BUY	$96.76 - $112.03 $642,970 - $744,439	6,645 Added 6.07%	116,066 $11.2 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $114,726 - $138,667	-1,124 Reduced 1.02%	109,421 $11.9 Million
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $3.19 Million - $3.89 Million	27,993 Added 33.91%	110,545 $13.1 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $372,815 - $456,491	3,227 Added 4.07%	82,552 $11.6 Million
Q3 2021 Nov 01, 2021	BUY	$116.66 - $129.06 $193,888 - $214,497	1,662 Added 2.14%	79,325 $9.37 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $1.19 Million - $1.4 Million	-11,210 Reduced 12.61%	77,663 $9 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $1.34 Million - $1.58 Million	12,308 Added 16.08%	88,873 $10.7 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $425,880 - $464,087	4,056 Added 5.59%	76,565 $8.38 Million
Q3 2020 Nov 04, 2020	BUY	$91.64 - $111.29 $4.71 Million - $5.72 Million	51,415 Added 243.74%	72,509 $7.89 Million
Q2 2020 Aug 06, 2020	BUY	$76.57 - $98.0 $85,375 - $109,270	1,115 Added 5.58%	21,094 $1.93 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $271,947 - $397,661	-4,329 Reduced 17.81%	19,979 $1.58 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $90,129 - $100,335	-1,148 Reduced 4.51%	24,308 $2.11 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $690,074 - $748,255	-8,432 Reduced 24.88%	25,456 $2.13 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $1,457 - $1,700	-20 Reduced 0.06%	33,888 $2.61 Million
Q1 2019 May 07, 2019	BUY	$66.22 - $80.06 $140,518 - $169,887	2,122 Added 6.68%	33,908 $2.71 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $399,063 - $452,081	6,087 Added 23.69%	31,786 $2.3 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $606,701 - $731,912	9,977 Added 63.46%	25,699 $1.77 Million
Q2 2018 Aug 08, 2018	BUY	$57.57 - $63.54 $203,682 - $224,804	3,538 Added 29.04%	15,722 $859,000
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $6,527 - $7,379	116 Added 0.96%	12,184 $710,000
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $49,976 - $53,504	931 Added 8.36%	12,068 $710,000
Q3 2017 Nov 15, 2017	BUY	$48.06 - $53.64 $38,736 - $43,233	806 Added 7.8%	11,137 $609,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,331	10,331 $498,000

Others Institutions Holding ABT

# of Institutions

3,190

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Account

Independent Advisor Alliance Abbott Laboratories Transaction History